Drugmaker Biogen Pulls Alzheimer's Drug Aduhelm
25 de mar. de 2024 ·
3m 19s
Descarga y escucha en cualquier lugar
Descarga tus episodios favoritos y disfrútalos, ¡dondequiera que estés! Regístrate o inicia sesión ahora para acceder a la escucha sin conexión.
Descripción
Drugmaker Biogen is pulling the plug on its controversial Alzheimer's drug Aduhelm, following disappointing sales. It had been expected to be a blockbuster product.Biogen says patients currently taking Aduhelm will...
mostra más
Drugmaker Biogen is pulling the plug on its controversial Alzheimer's drug Aduhelm, following disappointing sales. It had been expected to be a blockbuster product.Biogen says patients currently taking Aduhelm will have access to it until November 1, but patients taking the drug in clinical trials will lose access May 1.
mostra menos
Información
| Autor | David Happe |
| Organización | Tidings Podcast Network |
| Página web | - |
| Etiquetas |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
Comentarios